City of Hope, an innovative biomedical research, treatment and educational institution with over 5,000 employees, is dedicated to the prevention and cure of cancer and other life-threatening diseases and guided by a compassionate, patient-centered philosophy.
Founded in 1913 and headquartered in Duarte, California, City of Hope is a remarkable non-profit institution, where compassion and advanced care go hand-in-hand with excellence in clinical and scientific research. City of Hope is a National Cancer Institute designated Comprehensive Cancer Center and a founding member of the National Comprehensive Cancer Network, an alliance of the nation’s 20 leading cancer centers that develops and institutes standards of care for cancer treatment.
The T Cell Therapeutics Research Laboratory (TCTRL) overseen by Stephen Forman, M.D., is a fast-paced lab involved in cutting edge technology, research and clinical immunotherapeutic programs. The TCTLR currently has an opening for an Assistant Research Professor or Staff Scientist who will provide scientific leadership in the development of cell manufacturing platforms for ongoing clinical trials involving chimeric antigen receptor T cell therapies. The ideal candidate will have extensive experience in the fields of immunology and tissue culture, and some exposure to clinical trials. This position will oversee and develop clinical cell manufacturing procedures with a team of scientists highly trained in T cell preclinical and clinical research. This position also requires the ability to coordinate and report on studies that are performed in an effort to fine tune existing cell manufacturing processes.
The successful candidate will have the following qualifications: